Abuse-deterrent pharmaceutical compositions of opioids and other drugs

  • US 9,592,200 B2
  • Filed: 11/19/2015
  • Issued: 03/14/2017
  • Est. Priority Date: 07/05/2002
  • Status: Active Grant
First Claim
Patent Images

1. An abuse-deterrent oral dosage form comprising a plurality of microparticles, wherein each microparticle comprises a homogenous single phase comprising:

  • (a) oxycodone; and

    (b) one or more fatty acids;

    wherein the molar ratio of fatty acid to oxycodone is in excess of about 7;

    1 and the oxycodone is in the form of a fatty acid salt.

View all claims

    Thank you for your feedback